Fig. 1From: TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancera. High PD1 immunohistochemical expression on TILs (× 400, HPF. b. High CTLA4 immunohistochemical expression on TILs and tumor (× 400, HPF). c. Immunohistochemical expression of LAG-3 on TILs (× 400, HPF). d. Immunohistochemical expression of TIM3 on TILs (× 400, HPF)Back to article page